Portfolio company
Amili
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops microbiome diagnostic tests, probiotics and gut health therapies for consumers, hospitals and biotechnology firms using an Asian-centric database.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
Nexilico
This company develops a computational discovery platform for precision microbiome engineering to help pharmaceutical firms and healthcare providers design targeted therapies and personalised treatments.
Ani.AI
This company develops a digital platform using machine learning to analyse gut health and provide personalised fermented supplements for individual consumers.
Myota
This company develops patented prebiotic fibre blends and microbiome testing kits for individual consumers and food and beverage manufacturers.
Florey Biosciences
This company develops engineered probiotics for patients taking antibiotics to protect gut microbiome health and prevent related medical conditions.
SUN GENOMICS
The company produces custom probiotics and gut health tests for consumers using whole-genome DNA sequencing of stool samples to identify specific microbiome needs.
Jeevatva
This biotech company develops microbiome-based microbial products and prebiotics to restore human microbiome homeostasis for patients with metabolic conditions like type 2 diabetes.
Biomesense
This company develops automated biosensors and analytics software for continuous gut microbiome tracking for clinical researchers, biotechnology firms and pharmaceutical organisations.
